{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2923, 
        2929
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2936, 
        2950
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3132, 
        3138
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3158, 
        3168
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3782, 
        3788
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2895, 
        2904
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3139, 
        3148
      ]
    }
  ], 
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6188, 
        6211
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2745, 
        2772
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2673, 
        2678
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2696, 
        2701
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2789, 
        2794
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2856, 
        2861
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3377, 
        3382
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2679, 
        2692
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2777, 
        2787
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2795, 
        2803
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        694, 
        723
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6111, 
        6146
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2642, 
        2668
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2826, 
        2832
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2878, 
        2886
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3149, 
        3156
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3425, 
        3431
      ]
    }
  ], 
  "Neoplasm Descriptive Grade (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2971, 
        2983
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "FALSE POSITIVE", 
      "__annotator__": "Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4154, 
        4155
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2848, 
        2854
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2887, 
        2894
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3369, 
        3375
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2670, 
        2672
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5", 
      "__extent": [
        2693, 
        2695
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2713, 
        2715
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        2774, 
        2776
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2845, 
        2847
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3366, 
        3368
      ]
    }
  ], 
  "Synoptic Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3516, 
        3533
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D0658987^CLIA|eMARCPlus|TN Cancer Registry|20170918000102||ORU^R01^ORU_R01|201709180001020001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-51-003580^PathSys^44D0658987^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170906000000|||||||20170906000000|&Sentinel Lymph Node, Breast, Exc. of Lesion, requiring micro. margins, Breast, Exc. of Lesion, requiring micro. margins, PQRS Breast Cancer Resection|1538157219^^^^^^MD^^CMS^D^^^NPI||||||20170908000000|||F||||||C50.911^Malignant neoplasm of unspecified site of right female breast^I10~D05.11^Intraductal carcinoma in situ of right breast^I10|1487897187&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received fresh in a container labeled with the patient's name, date of birth, and \"right sentinel node #1\" is a fragment of tan-yellow to red lobulated fibroadipose tissue measuring 3.0 x 2.0 x 1.2 cm. The specimen is sectioned to identify a single lymph node, measuring 1.5 x 0.6 x 0.6 cm. This lymph node is bisected and submitted in entirety for frozen section diagnosis. Summary of sections: FS1, 2/1. The remainder of the tissue is entirely submitted in cassette 1A, 3/1. (FLC/ml3) 2. Received fresh is a right lumpectomy specimen which is received oriented by the surgeon with a long suture marking lateral, a short suture marking superior, and an uneven suture marking deep and skin present at superficial. The specimen weighs 16 g and measures 4 cm from anterior to posterior x 4 cm from medial to lateral x 2 cm from superior to inferior. The specimen is inked as follows: Superior-blue, inferior- green, anterior-red, posterior-black, medial-orange, lateral-yellow. (FLC/jh9) The specimen is serially sectioned from medial to lateral to identify an area of fibrosis and biopsy cavity within the medial aspect of the specimen and measuring approximately 1.1 cm in greatest dimension. This lesion approaches within 2 mm of the medial margin and 3 mm from the superior and inferior margins. (HMJ/jh9) Representative sections are submitted as follows:   2A - 2C, lesion to medial and inferior margins   2D, representative lateral margin.   2E, 2F, additional representative sections of grossly uninvolved breast tissue. All the sections are 1/1 except for 2D which is 2/1. (FLC/ml3) 3. \"Additional inferior margin.\" Received in formalin is a fragment of yellow lobulated adipose tissue which measures 2.9 x 2.0 x 0.6 cm. There is a suture present which marks the new margin. This area is inked blue, and the specimen is serially sectioned and entirely submitted in cassettes 3A and 3B, 2/1 each. (FLC/ml3)\n\n\nPath report.site of origin\n\n1. Right sentinel node 2. Right lumpectomy 3. Additional inferior margin\n\n\nPath report.final diagnosis\n\n1. Lymph node, right sentinel #1, excision:     One benign lymph node. 2. Breast, right lumpectomy:     Invasive mammary carcinoma, no special type (ductal) with micropapillary       features.     Intermediate combined histologic grade, intermediate proliferative       rate.     Tumor measures 11 mm in greatest dimension.     Associated intermediate grade ductal carcinoma in situ, cribriform type.     In-situ and invasive carcinoma focally involve the medial margin and are 2 mm       from the inferior margin.     All other margins are widely negative for in-situ or invasive carcinoma. 3. Breast, right additional inferior margin, excision:     Benign mammary parenchyma, negative for atypical breast proliferation or       malignancy. CANCER CHECKLIST: INVASIVE CARCINOMA OF THE BREAST 3.000.001.1000043 SPECIMEN  Procedure: Excision (less than total mastectomy)  Specimen Laterality: Right TUMOR  Tumor Site: Invasive Carcinoma: Not specified  Histologic Type: Invasive carcinoma of no special type (ductal) with micropapillary features  Glandular (Acinar) / Tubular Differentiation: Score 3 (< 10% of tumor area forming glandular / tubular structures)  Nuclear Pleomorphism: Score 2 (Cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)  Mitotic Rate: Score 2 (4-7 mitoses per mm2)  Overall Grade: Grade 2 (scores of 6 or 7)  Tumor Size: Greatest dimension of largest invasive focus: 11mm  Tumor Focality: Single focus of invasive carcinoma  Ductal Carcinoma In Situ (DCIS): DCIS is present in specimen, Negative for extensive intraductal component (EIC)  Size (Extent) of DCIS: Estimated size (extent) of DCIS: 3mm  Architectural Patterns: Cribriform  Nuclear Grade (see Table 2 in CAP Protocol): Grade II (intermediate)  Necrosis: Not identified  Lobular Carcinoma In Situ (LCIS): No LCIS in specimen Tumor Extent  Skin Invasion: Invasive carcinoma does not invade into the dermis or epidermis  Skeletal Muscle: No skeletal muscle is present Accessory Findings  Lymphovascular Invasion: Not identified  Dermal Lymphovascular Invasion: Not identified  Microcalcifications: Not identified  Treatment Effect: No known presurgical therapy MARGINS  Invasive Carcinoma Margins: Positive for invasive carcinoma  Specify Margin(s): Medial  Extent of Medial Margin Involvement: Unifocal  Specify Margin(s): Medial  Extent of Medial Margin Involvement: Unifocal LYMPH NODES  Number of Lymph Nodes with Macrometastases (> 2 mm): Specify number  Specify number: 0  Number of Lymph Nodes with Micrometastases (> 0.2 mm to 2 mm and / or > 200 cells): Specify number  Specify number: 0  Number of Lymph Nodes with Isolated Tumor Cells (<= 0.2 mm and <= 200 cells)#: Specify number  Specify number: 0  Number of Lymph Nodes Examined: Specify number  Specify number: 1  Number of Sentinel Nodes Examined: Specify number  Specify number: 1 PATHOLOGIC STAGE CLASSIFICATION (pTNM, AJCC 8th Edition)  TNM Descriptors: Not applicable  Primary Tumor (Invasive Carcinoma) (pT): pT1c: Tumor > 10 mm but <= 20 mm in greatest dimension Regional Lymph Nodes (pN)  Modifier: (sn): Only sentinel node(s) evaluated. If 6 or more nodes (sentinel or nonsentinel) are removed, this modifier should not be used.  Category (pN): pN0: No regional lymph node metastasis identified or ITCs only#\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.relevant Hx\n\nHistory - Right breast cancer\n\n\n"
}